Al Mayadeen English

  • Ar
  • Es
Al Mayadeen English

Slogan

  • News
    • Politics
    • Economy
    • Sports
    • Arts&Culture
    • Health
    • Miscellaneous
    • Technology
    • Environment
  • Articles
    • Opinion
    • Analysis
    • Blog
    • Features
  • Videos
    • NewsFeed
    • Video Features
    • Explainers
    • TV
    • Digital Series
  • Infographs
  • In Pictures
  • • LIVE
News
  • Politics
  • Economy
  • Sports
  • Arts&Culture
  • Health
  • Miscellaneous
  • Technology
  • Environment
Articles
  • Opinion
  • Analysis
  • Blog
  • Features
Videos
  • NewsFeed
  • Video Features
  • Explainers
  • TV
  • Digital Series
Infographs
In Pictures
  • Africa
  • Asia
  • Asia-Pacific
  • Europe
  • Latin America
  • MENA
  • Palestine
  • US & Canada
BREAKING
China inaugurates the Asian games in Hangzhou.
The Israeli soldiers launched smoke and sound grenades at the Lebanese side earlier.
Al Mayadeen correspondent: The Lebanese Army responded to the Israeli occupation by launching smoke grenades toward Israeli soldiers in the Shebaa Farms after they provoked them with projectiles.
Pope Francis says migrants "do not invade" Europe.
Iraqi Prime Minister Mohammed Shia Al-Sudani will be visiting Moscow in the next few weeks: Iraq's foreign ministry.
Palestinian Ministry of Health: 22 Palestinians were injured by Israeli occupation gunfire east of Gaza Strip
Palestinian Ministry of Health: 14 Palestinians were injured by Israeli occupation gunfire near the Israeli-erected fence east of Gaza Strip
Palestinian Ministry of Health: Seven Palestinians were injured by Israeli occupation gunfire east of Gaza Strip
Sources to Al Mayadeen: Israeli occupation prison administration transfers hunger-striking prisoner Kayed al-Fafsous to solitary confinement in Asqalan prison
Head of Crimea: Russian air defenses shot down cruise missiles over Crimea.

FDA approval of Alzheimer's drug Aduhelm ‘rife with irregularities’

  • By Al Mayadeen English
  • Source: Agencies
  • 30 Dec 2022 10:24

This comes against the backdrop of criticism as the FDA is expected to decide on approving another drug for treating the disease in January.

  • Probe: Alzheimer’s drug approval ‘rife with irregularities’
    Probe: Alzheimer’s drug approval ‘rife with irregularities’

Sources reported on Friday that the 2021 FDA's approval of an Alzheimer's drug called Aduhelm was "rife with irregularities" as an 18-month congressional investigation issued on Thursday found an "atypical collaboration" between FDA regulators and Aduhelm manufacturer, Biogen. 

According to the probe, investigators found that the company intended to "make history" when it set an "unjustifiably high" initial yearly price of $56,000 for the drug.

This comes against the backdrop of criticism as the FDA is expected to decide on approving another drug for treating the disease in January.

The report also found that there was an unusually high amount of phone exchanges between company officials and FDA delegates.

It also revealed that the company and the agency spent months preparing a report that did not account for substantial disagreement within the FDA about how to handle Aduhelm.

The report called on the agency to take "swift action" to make sure that any future approvals aren't met with "the same doubts about the integrity of FDA’s review."

Both the company and the FDA issued statements on Thursday to defend Aduhelm's approval process.

Biogen knew Aduhelm would dramatically affect Medicare. If just 250,000 patients got the drug, it would account for more than 25% of the Part B budget. If Aduhelm reached its full potential, it would cost taxpayers upward of $70 billion. pic.twitter.com/B2y46UrE95

— Damian Garde (@damiangarde) December 29, 2022

Related News

Alzheimer's drug approval optimistic amid promising results

UN report reveals cocaine in upward trend, meth market expands

Read more: Canada going as far as possible abuse with MAiD, hitting brakes needed

The FDA approved Aduhelm in 2021 under accelerated approval over the objections of its independent scientific advisors who felt the data failed to prove the drug's benefit to patients.

The company had reportedly halted two studies after results suggested that the drug wasn't giving the desired effects: slowing Alzheimer's deteriorating process. 

The FDA said the drug was efficient on the grounds that it reduced a buildup of plaque in the brain.

But three of the agency's advisors resigned in protest of these claims and the agency's then-acting chief was called for questioning. 

Medicare eventually declined to fund the drug, even after the yearly price was reduced to $28,000.

In a statement Thursday, FDA said its "decision to approve Aduhelm was based on our scientific evaluation of the data contained in the application, which is described in the approval materials. ... That said, the agency has already started implementing changes consistent with the Committee's recommendations."

On Biogen's part, it said "Alzheimer’s is a highly complex disease and we have learned from the development and launch of Aduhelm,” but that it “stands by the integrity of the actions we have taken."

Read more: Scientists develop new blood test for Alzheimer’s disease

  • Drug
  • Alzheimer's Disease

Most Read

Ukrainian soldiers ride an APC on the front line near Bakhmut, in the Donetsk region, on June 5, 2023 (AP)

US sees Ukrainian army demoralized, no chance to win: Seymour Hersh

  • Europe
  • 21 Sep 2023
Ukraine lost around 85% of its initial mobilized force: Field general

Ukraine lost around 85% of its initial mobilized force: Field general

  • Europe
  • 16 Sep 2023
'Israel's' railroad network targeted by cyberattack: Israeli media

'Israel's' railroad network targeted by cyberattack: Israeli media

  • Palestine
  • 16 Sep 2023
Old habits, linger … linger well past the time when old rituals (an Israeli PM visit to the Oval Office) had agency and the world hung on the outcome. (Al Mayadeen English; Illustrated by Arwa Makki)

Will a tripartite US-Saudi-Israeli ‘Deal’ make Any difference?

  • Opinion
  • 16 Sep 2023

Coverage

All
Morocco & Libya Disasters

Read Next

All
US Senator and wife indicted for bribery
US & Canada

US Senator Menendez, his wife indicted for bribery

Lula
Latin America

Lula to Zelensky: Military option will not solve Ukraine conflict

IOF transfer prisoner al-Fasfous to solitary confinement in Askalan
Palestine

IOF transfer prisoner al-Fasfous to solitary confinement in Askalan

Borrell says migration could be "dissolving force" for EU
Europe

Borrell says migration may be 'dissolving force' for EU: The Guardian

Al Mayadeen English

Al Mayadeen is an Arab Independent Media Satellite Channel.

All Rights Reserved

  • Privacy Policy
  • About Us
  • Contact Us
  • Authors
Android
iOS